Protein aging hypothesis of Alzheimer disease

Jozef Orpiszewski, Norbert Schormann, Barbara Kluve-Beckerman, Juris J. Liepnieks, Merrill Benson

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Alzheimer disease (AD), the most common form of aging-related neurodegenerative disorders, is associated with formation of fibrillar deposits of amyloid β-protein (Aβ). While the direct involvement of Aβ in AD has been well documented, the relations between Aβ production, amyloid formation, and neurodegeneration remain unknown. We propose that AD is initiated by a protein aging-related structural transformation in soluble Aβ. We hypothesize that spontaneous chemical modification of aspartyl residues in Aβ to transient succinimide induces a non-native conformation in a fraction of soluble Aβ, rendering it amyloidogenic and neurotoxic. Conformationally altered Aβ is characterized by increased stability in solution and the presence of a non-native β-turn that determines folding of Aβ in solution and the structure of Aβ subunits incorporated into amyloid fibrils. While the soluble 'non-native' Aβ is both the factor triggering the neurodegenerative cascade and the precursor of amyloid plaques, these two events result from interaction of Aβ with different sets of cellular components and need not coincide in space and time. Extensive literature data and experimental evidence are provided in support of this hypothesis.

Original languageEnglish
Pages (from-to)1255-1263
Number of pages9
JournalFASEB Journal
Volume14
Issue number9
StatePublished - 2000

Fingerprint

amyloid
Alzheimer disease
Amyloid
Alzheimer Disease
Aging of materials
Serum Amyloid A Protein
Proteins
proteins
Amyloid Plaques
Chemical modification
Neurodegenerative Diseases
Conformations
neurodegenerative diseases
rendering
Deposits
space and time

Keywords

  • Amyloid β-protein
  • Amyloidosis
  • Isoaspartate
  • Succinimide

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Orpiszewski, J., Schormann, N., Kluve-Beckerman, B., Liepnieks, J. J., & Benson, M. (2000). Protein aging hypothesis of Alzheimer disease. FASEB Journal, 14(9), 1255-1263.

Protein aging hypothesis of Alzheimer disease. / Orpiszewski, Jozef; Schormann, Norbert; Kluve-Beckerman, Barbara; Liepnieks, Juris J.; Benson, Merrill.

In: FASEB Journal, Vol. 14, No. 9, 2000, p. 1255-1263.

Research output: Contribution to journalArticle

Orpiszewski, J, Schormann, N, Kluve-Beckerman, B, Liepnieks, JJ & Benson, M 2000, 'Protein aging hypothesis of Alzheimer disease', FASEB Journal, vol. 14, no. 9, pp. 1255-1263.
Orpiszewski J, Schormann N, Kluve-Beckerman B, Liepnieks JJ, Benson M. Protein aging hypothesis of Alzheimer disease. FASEB Journal. 2000;14(9):1255-1263.
Orpiszewski, Jozef ; Schormann, Norbert ; Kluve-Beckerman, Barbara ; Liepnieks, Juris J. ; Benson, Merrill. / Protein aging hypothesis of Alzheimer disease. In: FASEB Journal. 2000 ; Vol. 14, No. 9. pp. 1255-1263.
@article{739c06e2c2a64762a174aaded8d3e1d3,
title = "Protein aging hypothesis of Alzheimer disease",
abstract = "Alzheimer disease (AD), the most common form of aging-related neurodegenerative disorders, is associated with formation of fibrillar deposits of amyloid β-protein (Aβ). While the direct involvement of Aβ in AD has been well documented, the relations between Aβ production, amyloid formation, and neurodegeneration remain unknown. We propose that AD is initiated by a protein aging-related structural transformation in soluble Aβ. We hypothesize that spontaneous chemical modification of aspartyl residues in Aβ to transient succinimide induces a non-native conformation in a fraction of soluble Aβ, rendering it amyloidogenic and neurotoxic. Conformationally altered Aβ is characterized by increased stability in solution and the presence of a non-native β-turn that determines folding of Aβ in solution and the structure of Aβ subunits incorporated into amyloid fibrils. While the soluble 'non-native' Aβ is both the factor triggering the neurodegenerative cascade and the precursor of amyloid plaques, these two events result from interaction of Aβ with different sets of cellular components and need not coincide in space and time. Extensive literature data and experimental evidence are provided in support of this hypothesis.",
keywords = "Amyloid β-protein, Amyloidosis, Isoaspartate, Succinimide",
author = "Jozef Orpiszewski and Norbert Schormann and Barbara Kluve-Beckerman and Liepnieks, {Juris J.} and Merrill Benson",
year = "2000",
language = "English",
volume = "14",
pages = "1255--1263",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "9",

}

TY - JOUR

T1 - Protein aging hypothesis of Alzheimer disease

AU - Orpiszewski, Jozef

AU - Schormann, Norbert

AU - Kluve-Beckerman, Barbara

AU - Liepnieks, Juris J.

AU - Benson, Merrill

PY - 2000

Y1 - 2000

N2 - Alzheimer disease (AD), the most common form of aging-related neurodegenerative disorders, is associated with formation of fibrillar deposits of amyloid β-protein (Aβ). While the direct involvement of Aβ in AD has been well documented, the relations between Aβ production, amyloid formation, and neurodegeneration remain unknown. We propose that AD is initiated by a protein aging-related structural transformation in soluble Aβ. We hypothesize that spontaneous chemical modification of aspartyl residues in Aβ to transient succinimide induces a non-native conformation in a fraction of soluble Aβ, rendering it amyloidogenic and neurotoxic. Conformationally altered Aβ is characterized by increased stability in solution and the presence of a non-native β-turn that determines folding of Aβ in solution and the structure of Aβ subunits incorporated into amyloid fibrils. While the soluble 'non-native' Aβ is both the factor triggering the neurodegenerative cascade and the precursor of amyloid plaques, these two events result from interaction of Aβ with different sets of cellular components and need not coincide in space and time. Extensive literature data and experimental evidence are provided in support of this hypothesis.

AB - Alzheimer disease (AD), the most common form of aging-related neurodegenerative disorders, is associated with formation of fibrillar deposits of amyloid β-protein (Aβ). While the direct involvement of Aβ in AD has been well documented, the relations between Aβ production, amyloid formation, and neurodegeneration remain unknown. We propose that AD is initiated by a protein aging-related structural transformation in soluble Aβ. We hypothesize that spontaneous chemical modification of aspartyl residues in Aβ to transient succinimide induces a non-native conformation in a fraction of soluble Aβ, rendering it amyloidogenic and neurotoxic. Conformationally altered Aβ is characterized by increased stability in solution and the presence of a non-native β-turn that determines folding of Aβ in solution and the structure of Aβ subunits incorporated into amyloid fibrils. While the soluble 'non-native' Aβ is both the factor triggering the neurodegenerative cascade and the precursor of amyloid plaques, these two events result from interaction of Aβ with different sets of cellular components and need not coincide in space and time. Extensive literature data and experimental evidence are provided in support of this hypothesis.

KW - Amyloid β-protein

KW - Amyloidosis

KW - Isoaspartate

KW - Succinimide

UR - http://www.scopus.com/inward/record.url?scp=0034039415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034039415&partnerID=8YFLogxK

M3 - Article

C2 - 10834947

AN - SCOPUS:0034039415

VL - 14

SP - 1255

EP - 1263

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 9

ER -